TRH (Thyrotropin-Releasing Hormone), also known as Protirelin, is a synthetic peptide that mimics the naturally occurring hypothalamic hormone responsible for stimulating the pituitary gland to release thyroid-stimulating hormone (TSH). TSH then acts on the thyroid gland to regulate the production of thyroid hormones, which are critical for metabolism, energy balance, growth, and overall endocrine function. Protirelin has been studied for its potential to support thyroid function and assess pituitary-thyroid axis activity in research and clinical settings. By influencing this hormonal cascade, TRH plays a key role in maintaining metabolic homeostasis and supporting proper physiological function.
In research or clinical contexts, TRH (Protirelin) is typically supplied as a lyophilized powder or injectable formulation and requires precise dosing for accurate results. It has been used in diagnostic testing to evaluate thyroid function, as well as in experimental research exploring its effects on neurological and metabolic pathways. While generally well tolerated, administration can occasionally lead to mild side effects such as transient flushing, nausea, or changes in heart rate. TRH is not widely approved for general therapeutic use beyond specific clinical or diagnostic indications, and professional guidance is essential for safe handling, dosing, and monitoring. Its ability to modulate the thyroid axis makes it a valuable tool in endocrine research and targeted experimental applications.
Reviews
There are no reviews yet.